Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Edison International due to a class action complaint alleging breaches of fiduciary duties by the board of directors [1] Group 1: Allegations and Claims - The class action complaint alleges that Edison made false and misleading statements regarding its Public Safety Power Shutoffs program, claiming it was used to mitigate wildfire risks, which was found to be false [2] - The complaint states that the misleading claims resulted in increased fire risk in California and heightened legal exposure for Edison [2] - As a result of these misleading statements, the lawsuit claims that investors suffered damages when the true information became public [2] Group 2: Legal Representation - Bragar Eagel & Squire, P.C. is representing long-term stockholders of Edison and is seeking information related to the claims [3] - The firm emphasizes that there is no cost or obligation for stockholders to inquire about their rights or interests regarding these matters [3] Group 3: Firm Background - Bragar Eagel & Squire, P.C. is a nationally recognized law firm with expertise in representing individual and institutional investors in complex litigation [4] - The firm operates in both New York and California, handling cases in state and federal courts across the country [4]

Core Viewpoint - A class action lawsuit has been filed against Iovance Biotherapeutics, Inc. for allegedly providing misleading statements about its growth potential and failing to capitalize on demand for its treatments during the class period from May 9, 2024, to May 8, 2025 [1][3]. Company Performance - Iovance announced its financial results for Q2 2024 on July 25, 2024, and reduced its revenue guidance for the full fiscal year 2024 due to several factors, including maintenance that reduced capacity, lower-than-expected Proleukin sales, and the variable pace of treatment initiation [4]. - Following the announcement of reduced guidance, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.8% in one day [4]. Legal Proceedings - The lawsuit is on behalf of all individuals and entities that purchased Iovance securities during the specified class period, with a deadline of July 14, 2025, for investors to apply as lead plaintiffs [1]. - The complaint alleges that the company concealed material adverse facts regarding its ability to meet demand for its treatments [3]. Investor Information - Investors who suffered losses or have questions regarding the lawsuit can contact the law firm Bragar Eagel & Squire, P.C. for more information [5].

Southwest said the cited claims weren’t credible. Photo: jason redmond/Agence France-Presse/Getty ImagesThe Transportation and Justice departments dropped a lawsuit against Southwest Airlines LUV 2.57 %increase; green up pointing triangle that accused the airline of overstuffing its schedule with flights it can’t operate on-time.Government lawyers on Friday filed a motion to dismiss the case in San Francisco federal court. The suit, filed in the waning days of the Biden administration, was part of an effort ...

Core Viewpoint - A securities class action lawsuit has been filed against Iovance Biotherapeutics, Inc. for allegedly misleading investors regarding the company's performance and treatment timelines for its product Amtagvi during the class period from May 9, 2024, to May 8, 2025 [1][2]. Group 1: Allegations and Company Performance - The lawsuit claims that Iovance made false statements and failed to disclose critical issues, including delays in treatment timelines at new Authorized Treatment Centers (ATCs) and inefficiencies in patient identification, leading to increased costs and reduced revenue [2]. - Iovance reported a significant decline in quarterly total product revenue, dropping to $49.3 million from $73.7 million in the previous quarter, and slashed its full fiscal year 2025 revenue guidance from $450 million - $475 million to $250 million - $300 million, representing a reduction of over 40% at the midpoint [3]. - Following the release of these financial results, Iovance's share price fell by $1.42, or 44.8%, closing at $1.75 per share on May 9, 2025, amid unusually high trading volume [3]. Group 2: Legal Proceedings - Investors who acquired shares of Iovance during the class period are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline of July 15, 2025 [4].

Group 1: CoreWeave (CRWV) - CoreWeave reported a net loss of $149.6 million or -$1.49 per share, but Q1 sales surged 420% year-over-year to $981.6 million, indicating strong future earnings potential [2] - Nvidia disclosed a major stake in CoreWeave, owning 24.18 million shares, and has secured a $4.1 billion deal with OpenAI, with other notable customers including Microsoft and Meta Platforms [3] - CoreWeave's stock spiked over 35% this week and has increased over 100% since its IPO, reaching an all-time high of $84 per share [4] Group 2: Cisco Systems (CSCO) - Cisco Systems exceeded both top and bottom-line expectations for its fiscal third quarter, with Q3 sales rising 11% to $14.15 billion compared to $12.7 billion a year ago [5][6] - The company's Security segment revenue climbed 54% to $2.01 billion, and it reported over $600 million in AI infrastructure orders during the quarter [6] - Cisco has announced collaboration with the AI Infrastructure Partnership (AIP) to invest in scalable AI data centers alongside Microsoft, BlackRock, and Nvidia [7] Group 3: CyberArk Software (CYBR) - CyberArk reported Q1 sales of $317.6 million, a 43% increase year-over-year, exceeding estimates of $305.66 million, with EPS rising 30% to $0.98 from $0.75 a share [11] - The company has integrated artificial intelligence into its identity security solutions, enhancing threat detection and response capabilities [10] - CyberArk's stock is trading over $350 a share and has increased 35% in 2025, with an impressive average earnings surprise of 44.33% over the last four quarterly reports [11][12] Group 4: Market Sentiment - The quarterly reports of CoreWeave, Cisco Systems, and CyberArk have generated positive investor sentiment, suggesting potential for further stock price increases as the market sentiment turns bullish and AI continues to drive growth [13]

Core Viewpoint - Tesla has amended its corporate bylaws to limit shareholders' ability to sue the company for breaches of fiduciary duties, requiring a minimum ownership threshold of 3% of outstanding shares to initiate such lawsuits [1][2][3]. Summary by Sections Corporate Bylaws Change - The new bylaw took effect on May 15, establishing that shareholders or groups must hold at least 3% of Tesla's issued and outstanding shares to maintain a derivative proceeding [2]. - Tesla's current market capitalization exceeds $1 trillion, meaning a 3% stake would be valued at over $30 billion [2]. Legal Context - The change leverages a Texas state law that allows corporations to impose ownership thresholds for shareholder lawsuits against insiders for fiduciary breaches [3]. - This law is particularly significant for Tesla, which is incorporated in Texas, as it creates a substantial barrier for potential lawsuits [4]. Historical Comparison - Previously, while incorporated in Delaware, a shareholder with just nine shares successfully initiated a lawsuit that led to the rescindment of Elon Musk's 2018 compensation package [4]. - The Delaware Chancery Court found that Musk had effectively controlled the company, and the board misled shareholders regarding the compensation plan [5]. Implications of Incorporation Change - Following the Tornetta decision, which prompted Musk to advise against incorporating in Delaware, Tesla moved its incorporation to Texas in June 2024 after receiving shareholder approval [6]. - Tesla is currently appealing the Tornetta decision, with the Delaware Supreme Court set to determine the fate of Musk's shares from the 2018 pay plan, valued at approximately $56 billion [7].

Group 1 - The article discusses the positions of various analysts regarding specific stocks, indicating that Anand Chokkavelu, Karl Thiel, and Keith Speights do not hold any positions in the mentioned stocks [1] - The Motley Fool has positions in and recommends Guardant Health, highlighting its investment interest in this company [1]

Core Viewpoint - Krispy Kreme, Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding its partnership with McDonald's and declining product demand [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Cameron v. Krispy Kreme, Inc., and it involves purchasers of Krispy Kreme securities from February 25, 2025, to May 7, 2025 [1]. - Investors have until July 15, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Krispy Kreme's executives made false statements about the profitability and demand for their products at McDonald's locations [3]. Group 2: Financial Performance - Krispy Kreme reported a net revenue of $375.2 million for the first quarter of 2025, representing a decline of 15.3% compared to the previous year [4]. - The company also reported a net loss of $33.4 million, compared to a net loss of $6.7 million in the prior year [4]. - Following the release of these financial results, Krispy Kreme's share price fell by nearly 25% [4]. Group 3: Partnership with McDonald's - The lawsuit claims that demand for Krispy Kreme products significantly declined at McDonald's locations after an initial marketing launch [3]. - It is alleged that this decline in demand contributed to decreasing average sales per door per week and posed risks to the partnership's sustainability [3]. - Krispy Kreme announced it would pause expansion into new McDonald's locations due to these challenges [3].

Core Viewpoint - Delta Air Lines is experiencing a notable stock performance, with a recent price of $50.92, reflecting a 1.27% increase, outperforming major indices like the S&P 500, Dow, and Nasdaq [1] Company Performance - Delta Air Lines' stock has increased by 23.08% over the past month, significantly surpassing the Transportation sector's gain of 12.07% and the S&P 500's gain of 9.81% [1] - The upcoming earnings disclosure is projected to show earnings of $1.97 per share, a year-over-year decline of 16.53%, with anticipated revenue of $16.13 billion, indicating a 3.2% decrease from the same quarter last year [2] - For the entire fiscal year, earnings are projected at $5.26 per share and revenue at $60.9 billion, reflecting declines of 14.61% and 1.2% respectively from the prior year [3] Analyst Estimates - Recent changes in analyst estimates suggest a favorable outlook on Delta Air Lines' business health and profitability, with the Zacks Consensus EPS estimate moving 2.25% lower in the past month [4][6] - Delta Air Lines currently holds a Zacks Rank of 3 (Hold), indicating a neutral position in the market [6] Valuation Metrics - Delta Air Lines has a Forward P/E ratio of 9.56, slightly above the industry average of 9.52, suggesting it is trading at a premium [7] - The company has a PEG ratio of 2.45, compared to the Transportation - Airline industry average of 1.04, indicating a higher valuation relative to expected earnings growth [8] Industry Context - The Transportation - Airline industry is ranked 180 out of over 250 industries, placing it in the bottom 28%, which may impact overall performance [9]

Core Viewpoint - Alphabet's stocks experienced a rise of over 1% following CEO Sundar Pichai's positive comments regarding the company's advancements in artificial intelligence (AI), outperforming the S&P 500 index which increased by 0.7% on the same day [1]. Group 1: AI Deployment and Competition - Pichai addressed concerns about potential disruption from competitors in the AI space during an interview on the All-In podcast, indicating that the perceived dilemma of competition is not a real issue for Alphabet [2][4]. - The company is actively enhancing its AI capabilities, with the Gemini AI platform integrated into Google search, which will soon feature an "AI mode" for a more interactive user experience [6]. Group 2: Industry Context and Comparisons - Other tech companies, such as Microsoft and Apple, are also advancing their AI functionalities, with Microsoft investing in OpenAI and Apple focusing on AI-driven search capabilities in its Safari browser [4][5]. - Despite the competition, Alphabet's commitment to AI development is evident, and its search engine remains a significant platform for AI utilization [8].